1)The Nobel Prize in Physiology or Medicine 2018 : NobelPrize.org. Nobel Media AB 2018. Fri. 7 Dec 2018. https://www.nobelprize.org/prizes/medicine/2018/summary/(2018年12月7日閲覧)
2)Chen DS, et al : Oncology meets immunology ; the cancer-immunity cycle. Immunity 39(1) : 1-10, 2013. PMID 23890059 〈がん免疫療法を理解するために必須のcancer-immunity cycleの丁寧な解説〉
3)Pardoll DM : The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4) : 252-264, 2012. PMID 22437870
4)Michot JM, et al : Immune-related adverse events with immune checkpoint blockade ; a comprehensive review. Eur J Cancer 54 : 139-148, 2016. PMID 26765102
5)Calabrese LH, et al : Rheumatic immune-related adverse events from cancer immunotherapy. Nat Rew Rheumato 14(10) : 569-579, 2018. PMID 30171203
6)June CH, et al : Is autoimmunity the Achilles' heel of cancer immunotherapy? Nat Med 23(5) : 540-547, 2017. PMID 28475571
7)Postow MA, et al : Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378(2) : 158-168, 2018. PMID 29320654
8)Postow MA, et al : Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378(2) : 158-168, 2018. PMID 29320654 〈irAEsについてまとめられたreview article。図表がわかりやすい〉
9)Brahmer JR, et al : Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy ; American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36(17) ; 1714-1768, 2018. PMID 29442540 〈米国臨床腫瘍学会とNational Comprehensive Cancer NetworkによるirAEsに対する評価・診断と治療の包括的なガイドライン〉
10)Johnson DB, et al : Immune checkpoint Inhibitor toxicity in 2018. JAMA 320(16) : 1702-1703, 2018. PMID 30286224 〈一般内科医が押さえておきたいirAEsの臨床的側面について短くまとめられている〉
11)門野岳史:免疫チェックポイント阻害剤による免疫関連副作用の実際.日本臨床免疫学会会誌40(2) : 83-89, 2017. 〈代表的なirAEsについて、日本語で簡潔かつ具体的な対策がまとめられている〉
12)Cappelli LC, et al : Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors ; a systematic review of the literature. Arthritis Care Res (Hoboken)69(11) : 1751-1763, 2017. PMID 27998041